You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Ablative Therapies

Showing 1 - 25 of 8,716
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Prostate Cancer Trial in Dallas (Ablative Therapy)

Not yet recruiting
  • Prostate Cancer
  • Ablative Therapy
  • Dallas, Texas
    UTSW
Jul 25, 2022

Renal Cancer Trial in Calgary, Edmonton

Recruiting
  • Renal Cancer
    • Calgary, Alberta, Canada
    • +1 more
    Apr 5, 2022

    Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial

    Active, not recruiting
    Has Results
    • Biliary Tract Neoplasms
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Mar 1, 2022

    Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

    Recruiting
    • Adenocarcinoma
    • +8 more
    • Radiotherapy targeted to the primary lesion
    • +7 more
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 7, 2023

    Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • Castration-Sensitive Prostate Cancer
    • Shanghai, Shanghai, China
    • +1 more
    Feb 4, 2023

    Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

    Completed
    • Advanced Epithelial Ovarian
    • +3 more
    • Basking Ridge, New Jersey
    • +5 more
    Mar 4, 2022

    Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH

    Recruiting
    • Castration-Resistant Prostatic Cancer
    • +4 more
    • GnRH agonist/antagonist
    • +3 more
    • Los Angeles, California
    • +3 more
    Apr 30, 2021

    Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body

    Recruiting
    • Prostate Cancer Metastatic
    • +2 more
    • stereotactic body radiotherapy
    • +2 more
    • Umeå, Umea, Sweden
    • +1 more
    May 19, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)

    Active, not recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Birmingham, Alabama
    • +13 more
    Jun 20, 2022

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Oligometastatic Prostate Cancer Trial (177Lu-PSMA)

    Not yet recruiting
    • Oligometastatic Prostate Cancer
    • (no location specified)
    Sep 26, 2022

    PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7

    Active, not recruiting
    • PSA Level Greater Than 0.03
    • +4 more
    • Antiandrogen Therapy
    • +2 more
    • Los Angeles, California
    • +1 more
    Oct 14, 2021

    High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)

    Recruiting
    • High-risk Prostate Cancer
    • Prostate Cancer
    • Houston, Texas
      Houston Methodist Hospital
    Apr 5, 2021

    Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Breast Cancer
    • +4 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 19, 2023

    Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 19, 2023

    NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 27, 2023

    Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Esophageal Cancer
    • +10 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 27, 2023

    Anal Dysplasia, Human Papillomavirus, Anal Cancer Trial in Vancouver, Ottawa, Toronto (The Hyfrecator ® 2000 Electrosurgical

    Terminated
    • Anal Dysplasia
    • +2 more
    • The Hyfrecator ® 2000 Electrosurgical System
    • Observation Alone
    • Vancouver, British Columbia, Canada
    • +3 more
    Jun 9, 2022

    Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

    Recruiting
    • Oligometastatic Prostate Carcinoma
    • +2 more
    • Placebo Administration
    • +3 more
    • Decatur, Illinois
    • +2 more
    Aug 11, 2022

    Prostate Cancer Trial in Baltimore (Radium-223, stereotactic ablative radiotherapy (SABR))

    Recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins
    May 25, 2022

    Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

    Not yet recruiting
    • Oligometastatic Hormone Sensitive Prostate Cancer
    • SBRT on all sites of metastatic disease+Apalutamide
    • Florence, Italy
      AOU Careggi Radiation Oncology Unit
    Jan 29, 2023

    Prostate Cancer Trial in Surrey, Victoria (stereotactic ablative radiotherapy, external beam radiation therapy, Zoladex ®)

    Active, not recruiting
    • Prostate Cancer
    • stereotactic ablative radiotherapy
    • +2 more
    • Surrey, British Columbia, Canada
    • +1 more
    Oct 26, 2020

    Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

    Recruiting
    • Prostate Adenocarcinoma
    • Leuprolide Acetate
    • +5 more
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

    Recruiting
    • Prostate Cancer
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins Hospital
    May 6, 2022